| Literature DB >> 35994324 |
Michelle Partogi1, Simon Gaviria-Valencia1, Mateo Alzate Aguirre1, Nancy J Pick1, Huzefa M Bhopalwala1, Barbara A Barry1, Vinod C Kaggal1, Christopher G Scott1, Maya E Kessler1, Matthew M Moore1, Jay D Mitchell1, Rajeev Chaudhry1, Robert P Bonacci1, Adelaide M Arruda-Olson1.
Abstract
BACKGROUND: Clinical practice guidelines recommend antiplatelet and statin therapies as well as blood pressure control and tobacco cessation for secondary prevention in patients with established atherosclerotic cardiovascular diseases (ASCVDs). However, these strategies for risk modification are underused, especially in rural communities. Moreover, resources to support the delivery of preventive care to rural patients are fewer than those for their urban counterparts. Transformative interventions for the delivery of tailored preventive cardiovascular care to rural patients are needed.Entities:
Keywords: atherosclerotic cardiovascular diseases; community health; participatory design; rural health; secondary prevention; sociotechnical; team-based care
Mesh:
Year: 2022 PMID: 35994324 PMCID: PMC9446142 DOI: 10.2196/27333
Source DB: PubMed Journal: J Med Internet Res ISSN: 1438-8871 Impact factor: 7.076
Figure 1Project phased-design approach. LPN: licensed practical nurse; NP: nurse practitioner; PA: physician assistant; RN: registered nurse.
Figure 2Cardiovascular-Patient Appointment Note handout summarizing the status of use of guideline recommendations by a patient with atherosclerotic cardiovascular disease. Handouts were given to primary care providers before encounters.
Figure 3Design of the reaching out experiment.
Figure 4The final resulting intervention design is a sociotechnical system—a combination of roles, processes, and technology—to enable primary care teams to improve the delivery of cardiovascular prevention strategies. CDS: clinical decision support.
Performance metrics for billing code algorithms in the Cohort Knowledge Solution.
| Type of ASCVDa | Charts reviewed, N | Sensitivity, % | Positive predictive value, % | F1 score, % |
| Coronary artery disease | 189 | 96 | 94 | 95 |
| Peripheral artery disease | 140 | 64 | 100 | 78 |
| Stroke | 156 | 98 | 81 | 89 |
aASCVD: atherosclerotic cardiovascular disease.
Figure 5Cohort Knowledge Solution platform redesigned after user testing with health care professionals.
Figure 6Screenshot of the verification survey sent via the Mayo Clinic patient portal app.
Figure 7The regionalization of the care hub model.
Characteristics of patients assigned to the control and intervention arms (N=369).
| Clinical variablesa | Control arm (n=182) | Intervention arm (n=187) |
| Age (years), mean (SD) | 71 (13) | 71 (14) |
| Sex (male), n (%) | 92 (50.5) | 95 (50.8) |
| Race (White), n (%) | 167 (91.8) | 174 (93) |
| Ethnicity (“not Hispanic or Latino”), n (%) | 171 (94) | 178 (95.2) |
| Married, n (%) | 94 (51.6) | 103 (55.1) |
| Taking antiplatelet medications, n (%) | 120 (65.9) | 121 (64.7) |
| Taking statin medications, n (%) | 111 (61) | 112 (59.9) |
| Nonsmokers, n (%) | 132 (72.5) | 135 (72.2) |
| Blood pressure at goal, n (%) | 87 (47.8) | 89 (47.6) |
aTwo-sample 2-tailed t tests were used to compare means, and chi-square tests were used for comparison of percentages; all P values comparing the control and intervention arms were not significant (P>.05).
Figure 8Pilot trial design. V4: cardiovascular guideline recommendations. *Extenuating circumstances included dementia or cognitive impairment, end-stage medical conditions on hospice care, active cancer treatment, hospitalization during the pilot, patient relocation to a different county and no longer receiving medical care from the Mayo Clinic Health System Austin, upcoming cardiology appointment within 3 months of the pilot, or other medical conditions that did not require the use of V4.
Number of encounters for the delivery of cardiovascular guideline recommendations (V4) by nonphysician health care professionals during the pilot (after crossover; N=369).
|
| Control arm (n=215)a, n (%) | Intervention arm (n=154)a, n (%) | |
| Nursing encounters for the delivery of | 48 (22.3) | 51 (33.1) | .02 |
| Pharmacist encounters for the delivery of | 1 (0.5) | 31 (20.1) | <.001 |
| Tobacco cessation coach encounters for the delivery of tobacco discontinuation strategies | 3 (1.4) | 30 (19.5) | <.001 |
aTotal number of patients in each arm after crossing over.
bTwo-sample 2-tailed t tests were used to compare means, and chi-square tests were used for comparison of percentages; for all analyses, P<.05 was considered significant.